231 related articles for article (PubMed ID: 35114896)
1. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States.
Scott A; Chambers R; Reimbaeva M; Atwell J; Baillon-Plot N; Draica F; Tarallo M
J Med Econ; 2022; 25(1):287-298. PubMed ID: 35114896
[TBL] [Abstract][Full Text] [Related]
2. Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
Hu T; Miles AC; Pond T; Boikos C; Maleki F; Alfred T; Lopez SMC; McGrath L
J Med Econ; 2024; 27(1):324-336. PubMed ID: 38343288
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
4. Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.
Kim N; Aly A; Craver C; Garvey WT
J Med Econ; 2023; 26(1):376-385. PubMed ID: 36812069
[TBL] [Abstract][Full Text] [Related]
5. Inpatient Hospital Costs for COVID-19 Patients in the United States.
Ohsfeldt RL; Choong CK; Mc Collam PL; Abedtash H; Kelton KA; Burge R
Adv Ther; 2021 Nov; 38(11):5557-5595. PubMed ID: 34609704
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of COVID-19 for employers and employees in the United States.
Sell H; Schaible K; Gouveia-Pisano JA; Yehoshua A; Malhotra D; Di Fusco M; Cha-Silva AS; Andersen KM; Nicholls L; Landi SN; Rolland C; Judy J
J Med Econ; 2024; 27(1):267-278. PubMed ID: 38294896
[TBL] [Abstract][Full Text] [Related]
7. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
[TBL] [Abstract][Full Text] [Related]
8. Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States.
Zhdanava M; Teeple A; Pilon D; Shah A; Caron-Lapointe G; Joshi K
J Med Econ; 2023; 26(1):691-700. PubMed ID: 37130075
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings.
Blauvelt A; Shi N; Murage MJ; Kern SA; Somani N; Burge R; Ridenour TL; Lew CR; Zimmerman NM; Zhu B
J Med Econ; 2022; 25(1):741-749. PubMed ID: 35615978
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Healthcare Burden of Patients with Schizophrenia Treated in a US Integrated Healthcare System.
Mahabaleshwarkar R; Lin D; Joshi K; Fishman J; Blair T; Hetherington T; Palmer P; Patel C; Krull C; Tcheremissine OV
J Ment Health Policy Econ; 2021 Jun; 24(2):47-59. PubMed ID: 34151777
[TBL] [Abstract][Full Text] [Related]
12. The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review.
Pierre V; Draica F; Di Fusco M; Yang J; Nunez-Gonzalez S; Kamar J; Lopez S; Moran MM; Nguyen J; Alvarez P; Cha-Silva A; Gavaghan M; Yehoshua A; Stapleton N; Burnett H
J Med Econ; 2023; 26(1):1519-1531. PubMed ID: 37964554
[TBL] [Abstract][Full Text] [Related]
13. Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare population.
Mantel J; Chitnis AS; Ruppenkamp J; Holy CE; Daccach J
J Med Econ; 2021; 24(1):10-18. PubMed ID: 33267624
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States.
Di Fusco M; Shea KM; Lin J; Nguyen JL; Angulo FJ; Benigno M; Malhotra D; Emir B; Sung AH; Hammond JL; Stoychev S; Charos A
J Med Econ; 2021; 24(1):308-317. PubMed ID: 33555956
[TBL] [Abstract][Full Text] [Related]
15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
16. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
Wattanakamolkul K; Nakayama Y
J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States.
Kaye DR; Khilfeh I; Muser E; Morrison L; Kinkead F; Lefebvre P; Pilon D; George D
J Med Econ; 2024; 27(1):381-391. PubMed ID: 38420699
[TBL] [Abstract][Full Text] [Related]
18. The real-world economic impact of home-based video electroencephalography: the payer perspective.
Slater JD; Eaddy M; Butts CM; Meltser I; Murty S
J Med Econ; 2019 Oct; 22(10):1030-1040. PubMed ID: 31237168
[No Abstract] [Full Text] [Related]
19. Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
Stein EM; Bonifacio G; Latrémouille-Viau D; Shi S; Guérin A; Wu EQ; Sadek I; Cao X
J Med Econ; 2021; 24(1):234-243. PubMed ID: 33472483
[TBL] [Abstract][Full Text] [Related]
20. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
